Deregulated NFATc1 activity transforms murine fibroblasts via an autocrine growth factor-mediated Stat3-dependent

Lucio Lagunas1, Neil A Clipstone

  • 1Department of Pharmacology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153, USA.

Insights

Constitutive activation of nuclear factor of activated T cells c1 (NFATc1) drives cancer development by inducing autocrine factors. These factors activate Stat3 signaling, a crucial step in NFATc1-mediated cell transformation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The nuclear factor of activated T cells (NFAT) family, particularly NFATc1, is increasingly linked to tumorigenesis.
  • Constitutive NFAT pathway activation is observed in human cancers, contributing to tumor progression.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind the oncogenic potential of deregulated NFAT activity.
  • To investigate the role of NFATc1 in cell transformation and identify downstream signaling pathways.

Main Methods:

  • Ectopic expression of constitutively active NFATc1 (caNFATc1) in murine 3T3-L1 fibroblasts.
  • Analysis of secreted autocrine factors and their effect on Stat3 phosphorylation.
  • Utilizing JAK kinase inhibitors and shRNA-mediated Stat3 depletion.

Main Results:

  • caNFATc1 expression induced secretion of autocrine factors promoting a transformed phenotype.
  • NFATc1-induced autocrine factors activated Stat3 tyrosine phosphorylation via a JAK kinase-dependent pathway.
  • Stat3 depletion significantly reduced caNFATc1-induced fibroblast transformation in murine and human cell lines.

Conclusions:

  • Constitutive NFATc1 activity transforms cells through an autocrine pathway.
  • This transformation is critically dependent on the activation of the Stat3 transcription factor.
  • Findings provide new insights into the oncogenic role of NFATc1 in cancer development.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...